H. Shaw

T. Pawlik, M. Ross, J. Gershenwald, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study.

J. Thompson, W. McCarthy, H. Shaw, 1988, Surgery, gynecology & obstetrics.

Effect of Smoking on the Recurrence of Malignant Melanoma

W. McCarthy, H. Shaw, G. Milton, 1979, The Medical journal of Australia.

CUTANEOUS MALIGNANT MELANOMA: OCCUPATION AND PROGNOSIS

V. McGovern, H. Shaw, G. Milton, 1981, The Medical journal of Australia.

Detection of First Relapse in Cutaneous Melanoma Patients: Implications for the Formulation of Evidence-Based Follow-up Guidelines

S. Soong, A. Francken, H. Hoekstra, 2007, Annals of Surgical Oncology.

Occult primary malignant melanoma: Factors influencing survival

W. McCarthy, H. Shaw, G. Milton, 1977, The British journal of surgery.

PROGNOSTIC HISTOPATHOLOGICAL FACTORS IN MALIGNANT MELANOMA

C. Balch, S. Soong, W. McCarthy, 1985, Pathology.

Sentinel node mapping for melanoma: results of trials and current applications.

H. Shaw, J. Thompson, 2007, Surgical oncology clinics of North America.

Prognostic significance of a polypoid configuration in malignant melanoma

V. McGovern, H. Shaw, G. Milton, 1983, Histopathology.

The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma

R. Scolyer, S. McCarthy, H. Shaw, 2006, Journal of cutaneous pathology.

Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma

H. Shaw, John Thompson, John F. Thompson, 2002, Cancer.

Follow‐up schedules after treatment for malignant melanoma

S. Soong, A. Francken, H. Hoekstra, 2008, The British journal of surgery.

Detection of second primary cutaneous melanomas.

J. Thompson, A. Francken, H. Shaw, 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

High-resolution ultrasound to diagnose melanoma metastases in patients with clinically palpable lymph nodes.

J. Thompson, W. McCarthy, R. Uren, 1999, Australasian radiology.

Elective lymph node dissection for melanoma: Two perspectives

N. Cascinelli, M. Santinami, W. McCarthy, 1992, World Journal of Surgery.

Should Tumor Mitotic Rate and Patient Age, As Well As Tumor Thickness, be Used to Select Melanoma Patients for Sentinel Node Biopsy?

H. Shaw, J. Thompson, 2004, Annals of Surgical Oncology.

Klinik (Symptomatologie, klinische Diagnose und Differentialdiagnose)

H. Shaw, G. Milton, C. M. Balch, 1988 .

Comparison of two methods of treating primary malignant melanomas clark IV and V, thickness 1.5 mm and greater, localized on the extremities. Wide surgical excision with and without adjuvant regional perfusion

M. Nap, H. Shaw, H. Koops, 1986, Cancer.

Survival superiority of females with melanoma.

J. Thompson, W. McCarthy, H. Shaw, 1994, Archives of surgery.

Sentinel Node Positive Melanoma Patients: Prediction and Prognostic Significance of Nonsentinel Node Metastases and Development of a Survival Tree Model

Dung-Tsa Chen, Hui-Yi Lin, Richard A. Scolyer, 2010, Annals of Surgical Oncology.

The Sydney Melanoma Unit--a multidisciplinary melanoma treatment center.

J. Stretch, W. McCarthy, H. Shaw, 2003, The Surgical clinics of North America.

Primary mucosal and glans penis melanomas: the Sydney Melanoma Unit experience.

J. Thompson, W. McCarthy, H. Shaw, 1999, The Australian and New Zealand journal of surgery.

Cutaneous melanomas exhibiting unusual biologic behavior

S. McCarthy, W. McCarthy, H. Shaw, 1992, World Journal of Surgery.

Immunohistochemical stains fail to increase the detection rate of micrometastatic melanoma in completion regional lymph node dissection specimens

R. Scolyer, S. McCarthy, J. Stretch, 2004, Melanoma research.

Predicting survival and recurrence in localized melanoma: A multivariate approach

Charles M. Balch, C. Balch, S. Soong, 1992, World Journal of Surgery.

Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (> 5 mm)

J. Thompson, S. McCarthy, K. Crotty, 1998, Histopathology.

The prognosis of patients with thick primary melanomas: Is regional lymph node status relevant, and does removing positive regional nodes influence outcome?

H. Shaw, J. Thompson, 2002, Annals of Surgical Oncology.

Prognosis in patients with thin malignant melanoma: influence of regression

V. McGovern, H. Shaw, G. Milton, 1983, Histopathology.

Lymphatic Drainage From Peri-Umbiiical Skin to Internal Mammary Nodes

W. McCarthy, R. Uren, H. Shaw, 1995, Clinical nuclear medicine.

Rare variants of malignant melanoma

H. Shaw, G. Milton, 1992, World Journal of Surgery.

Re: Sydney Melanoma Unit patients and Multicenter Selective Lymphadenectomy Trial protocol

H. Shaw, J. F. Thompson, 2006 .

Failure to remove true sentinel nodes can cause failure of the sentinel node biopsy technique: Evidence from antimony concentrations in false-negative sentinel nodes from melanoma patients

R. Scolyer, S. McCarthy, J. Stretch, 2004, Annals of Surgical Oncology.

Time for comprehensive reporting of MSLT-I – Authors' reply

R. Uren, H. Shaw, J. Thompson, 2006 .

The prognostic significance of isolated immunohistochemically positive cells in sentinel lymph nodes of melanoma patients.

R. Scolyer, R. Murali, H. Shaw, 2008, The American journal of surgical pathology.

Smoking and the development of metastases from malignant melanoma

H. Shaw, G. Milton, 1981, International Journal of Cancer.

Cutaneous melanomas that defy conventional prognostic indicators.

J. Thompson, S. McCarthy, W. McCarthy, 1996, Seminars in oncology.

Elective lymph node dissection.

C. O'brien, C. Ingvar, A. Coates, 1995, Journal of the American College of Surgeons.

SUBUNGUAL MALIGNANT MELANOMA: A DISEASE ENTITY SEPARATE FROM OTHER FORMS OF CUTANEOUS MELANOMA

W. McCarthy, H. Shaw, G. Milton, 1985, The Australasian journal of dermatology.

Skin cancers: diagnostic ability compared with diagnostic accuracy

H. Shaw, J. K. Rivers, J. K. Rivers, 1989, The Medical journal of Australia.

EVIDENCE SYNTHESIS Genesis , Validation , and Critique of the ABCDs In

A. Kopf, D. Rigel, R. Friedman, 2004 .

Polypoid melanoma is not rare

J. Thompson, H. Shaw, J. Thompson, 1996, The British journal of dermatology.

Melanoma: an historical perspective

W. McCarthy, H. Shaw, Neville C. Davis, 2003 .

Who should treat patients with primary melanoma?

H. Shaw, J. Thompson, 2005, The British journal of dermatology.

Ultra‐late recurrence (15 years or longer) of cutaneous melanoma

H. Shaw, J. Thompson, William McCarthy, 1998, Cancer.

Regarding pedunculated malignant melanoma.

J. Thompson, H. Shaw, 2000, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

The effects of surgical treatment on survival and local recurrence of cutaneous malignant melanoma

D. English, C. Ingvar, C. Holman, 1992, Cancer.

Contributors and Participants

D. Cox, A. Kong, N. Mendell, 1982 .

Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients

R. Scolyer, R. Gutzmer, H. Shaw, 2007, Histopathology.

Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria.

A. Kopf, D. Rigel, R. Friedman, 2004, JAMA.

Follow‐up schedules after treatment for malignant melanoma

S. Soong, A. Francken, H. Hoekstra, 2008, British Journal of Surgery.

Late recurrence of melanoma.

W. McCarthy, H. Shaw, 1992, Journal of the American Academy of Dermatology.